Facial Wrinkles Clinical Trial
Official title:
Efficacy and Safety of a Cutaneous Formulation of Gonyautoxin 2/3 (GTX 2/3) for the Treatment of Facial Wrinkles. Study # CLN 08-003.
The main objective of the trial is to determine whether the current topical formulation of
GTX 2/3 reduces the wrinkling of the skin (crow's feet) after a single application
Other evaluation criteria include: safety assessment and local tolerance, depth of facial
wrinkles (video microscopy imaging).
This is a single volunteer group study. Each volunteer will be her own control. A volunteer will receive the active product containing cream on one side of her face and will receive the placebo cream on the other side. ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01447342 -
A Study to Evaluate the Safety and Effectiveness of the Cryo-Touch II Device for the Treatment of Forehead and/or Glabellar Lines
|
Phase 2/Phase 3 | |
| Completed |
NCT00978887 -
Retorna Facial Cream in the Treatment of Facial Wrinkles
|
Phase 3 | |
| Completed |
NCT00414544 -
Evaluation of the Safety and Efficacy of CosmetaLife™ for the Correction of Nasolabial Folds
|
Phase 2 | |
| Completed |
NCT00888914 -
Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines
|
Phase 2 | |
| Completed |
NCT00877279 -
Multicenter Study of the Safety and Efficacy of Dermal Filler, Belotero® Soft
|
Phase 3 | |
| Completed |
NCT01124565 -
Safety Study of Two Repeat Doses of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults
|
Phase 2 | |
| Completed |
NCT00922623 -
Safety and Effectiveness of Belotero® in Subjects With Fitzpatrick Phototypes IV Through VI
|
N/A | |
| Not yet recruiting |
NCT03836638 -
The Impact of Age on Botulinum Toxin Potency in Facial Rhytides Treatment
|
N/A | |
| Not yet recruiting |
NCT06322875 -
A Clinical Study to Evaluate the Efficacy and Satisfaction of RHC Serum Combined With RHC(III) Injection
|
N/A | |
| Completed |
NCT01566396 -
Evaluation of Safety and Efficacy of the 3F Applicator (A3F) for Treatment of Facial Wrinkles
|
N/A | |
| Completed |
NCT01151436 -
Global Management of Facial Rejuvenation With a New Range of Hyaluronic Acid Dermal Fillers
|
N/A | |
| Completed |
NCT06321770 -
Oral Supplementation With Active Collagen Peptides and Skin Health Improvement
|
N/A | |
| Completed |
NCT01379365 -
Cryo-Touch III Refinement Study Investigational Plan
|
Phase 2/Phase 3 | |
| Completed |
NCT00288470 -
A Double-blinded Evaluation of Safety and Efficacy of Hylaform and Hylaform Plus Compared to Zyplast.
|
N/A | |
| Completed |
NCT02122536 -
Split-Face Prospective Study Comparing Botox to Xeomin for the Treatment of Facial Wrinkles
|
N/A | |
| Completed |
NCT01167140 -
Cryo-Touch II for the Treatment of Wrinkles
|
Phase 2/Phase 3 | |
| Completed |
NCT00968825 -
Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines
|
Phase 2 | |
| Completed |
NCT03286283 -
The Use of J-Plasma® for Dermal Resurfacing
|
N/A | |
| Completed |
NCT01064518 -
Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults
|
Phase 2 | |
| Completed |
NCT00417469 -
A Study to Compare Subject Comfort During and After Injections With the Study Products and the Safety of the Non-FDA Approved Product for the Correction of Nasolabial Folds (NLFs)
|
Phase 3 |